Fig. 3From: Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinomaGPRC5A repression predicts aggressive clinicopathological characteristics and poor prognosis in HNSCC patients. a Representative images (×100 and ×400) of GPRC5A IHC staining in HNSCC with different differentiation grades. b IHC scores of GPRC5A expression for HNSCC of well differentiated (Grade 1), moderately differentiated (Grade 2), and poorly differentiated (Grade 3). c Low GPRC5A expression group shows a relative worse 5-year overall survival (data from Oncomine by Rickman et al.). d Low GPRC5A expression group shows a relative worse 5-year distant metastasis-free survival (data from Oncomine by Rickman et al.)Back to article page